118 related articles for article (PubMed ID: 38247572)
21. Clinical Utility of Pretreatment and 3-Month
Mayo Z; Seyedin SN; Mallak N; Mott SL; Menda Y; Graham M; Anderson C
Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):595-600. PubMed ID: 30808209
[TBL] [Abstract][Full Text] [Related]
22. Prediction of extranodal extension in oropharyngeal cancer patients and carcinoma of unknown primary: value of metabolic tumor imaging with hybrid PET compared with MRI and CT.
Nemmour A; Stadler TM; Maurer A; Kovacs Z; Serrallach B; Born D; Nemes CM; Broglie MA; Pazahr S; Rupp NJ; Hüllner MW; Stoeckli SJ; Morand GB
Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1973-1981. PubMed ID: 36471046
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of cell proliferation imaging with 4DST PET/CT for predicting the prognosis of patients with esophageal cancer: a comparison study with FDG PET/CT.
Hotta M; Minamimoto R; Toyohara J; Nohara K; Nakajima K; Takase K; Yamada K
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2615-2623. PubMed ID: 33438100
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of 18F-FDG PET/MRI in patients with advanced oropharyngeal and hypopharyngeal squamous cell carcinoma.
Pace L; Nicolai E; Cavaliere C; Basso L; Garbino N; Spinato G; Salvatore M
Ann Nucl Med; 2021 Apr; 35(4):479-484. PubMed ID: 33575927
[TBL] [Abstract][Full Text] [Related]
25. Multiparametric functional MRI and
Martens RM; Koopman T; Lavini C; Ali M; Peeters CFW; Noij DP; Zwezerijnen G; Marcus JT; Vergeer MR; Leemans CR; de Bree R; de Graaf P; Boellaard R; Castelijns JA
Eur Radiol; 2021 Feb; 31(2):616-628. PubMed ID: 32851444
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic Accuracy of
Murtojärvi S; Malaspina S; Kinnunen I; Tuokkola T; Honka MJ; Saunavaara V; Tolvanen T; Schrey A; Kemppainen J
Contrast Media Mol Imaging; 2022; 2022():8676787. PubMed ID: 36082064
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of FDG-PET volumetric parameters in patients with p16-positive oropharyngeal squamous cell carcinoma who received curative resection followed by postoperative radiotherapy or chemoradiotherapy.
Kim KH; Lee J; Chang JS; Lee CG; Yun M; Choi EC; Kim SH; Keum KC
Head Neck; 2016 Oct; 38(10):1515-24. PubMed ID: 27062085
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance and predictive performance of volume-based parameters of F-18 FDG PET/CT in squamous cell head and neck cancers.
Sager S; Asa S; Yilmaz M; Uslu L; Vatankulu B; Halaç M; Sönmezoglu K; Kanmaz B
J Cancer Res Ther; 2014; 10(4):922-6. PubMed ID: 25579529
[TBL] [Abstract][Full Text] [Related]
29. Predictive value of SUV-based parameters derived from pre-treatment (18)F-FLT PET/CT for short-term outcome with head and neck cancers.
Hoshikawa H; Yamamoto Y; Mori T; Kishino T; Fukumura T; Samukawa Y; Mori N; Nishiyama Y
Ann Nucl Med; 2014 Dec; 28(10):1020-6. PubMed ID: 25179522
[TBL] [Abstract][Full Text] [Related]
30. Accuracy of (18) FDG PET-CT for treatment evaluation 3 months after completion of chemoradiotherapy for head and neck squamous cell carcinoma: 2-year minimum follow-up.
Sagardoy T; Fernandez P; Ghafouri A; Digue L; Haaser T; de Clermont-Galleran H; Castetbon V; de Monès E
Head Neck; 2016 Apr; 38 Suppl 1():E1271-6. PubMed ID: 26315809
[TBL] [Abstract][Full Text] [Related]
31. The role of metabolic tumor parameters predicting cervical lymph node metastasis in patients with head and neck squamous cell carcinoma.
Goksel S; Erdivanli OC; Bulbul O; Dursun E
J Cancer Res Ther; 2022; 18(4):1045-1051. PubMed ID: 36149160
[TBL] [Abstract][Full Text] [Related]
32. Use of Diffusion-Weighted Imaging and
Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
[TBL] [Abstract][Full Text] [Related]
33. Use of positron emission tomography/ computed tomography in the initial staging of head and neck squamous cell carcinoma: Accuracy in evaluation of the primary site of the tumor, metastases to cervical lymph nodes, and distant metastases.
Krátká Z; Paska J; Kavka A; Jaruskova M; Lohynska R; Lickova K; Cocek A
Otolaryngol Pol; 2022 Sep; 76(6):14-21. PubMed ID: 36805981
[TBL] [Abstract][Full Text] [Related]
34. Association of Fludeoxyglucose F 18-Labeled Positron Emission Tomography and Computed Tomography With the Detection of Oropharyngeal Cancer Recurrence.
Sivarajah S; Isaac A; Cooper T; Zhang H; Puttagunta L; Abele J; Biron V; Harris J; Seikaly H; O' Connell DA
JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1037-1043. PubMed ID: 30242338
[TBL] [Abstract][Full Text] [Related]
35. FDG-PET prediction of head and neck squamous cell cancer outcomes.
Schwartz DL; Rajendran J; Yueh B; Coltrera MD; Leblanc M; Eary J; Krohn K
Arch Otolaryngol Head Neck Surg; 2004 Dec; 130(12):1361-7. PubMed ID: 15611393
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of preoperative 18F-FDG PET/CT for primary head and neck squamous cell carcinoma.
Joo YH; Yoo IeR; Cho KJ; Park JO; Nam IC; Kim CS; Kim MS
Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1685-91. PubMed ID: 23949547
[TBL] [Abstract][Full Text] [Related]
37. Pre-CCRT 18-fluorodeoxyglucose PET-CT improves survival in patients with advanced stages p16-negative oropharyngeal squamous cell carcinoma via accurate radiation treatment planning.
Chen TM; Chen WM; Chen M; Shia BC; Wu SY
J Otolaryngol Head Neck Surg; 2023 Feb; 52(1):14. PubMed ID: 36782296
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088
[TBL] [Abstract][Full Text] [Related]
39. Is there an additive value of 18 F-FDG PET-CT to CT/MRI for detecting nodal metastasis in oropharyngeal squamous cell carcinoma patients with palpably negative neck?
Sohn B; Koh YW; Kang WJ; Lee JH; Shin NY; Kim J
Acta Radiol; 2016 Nov; 57(11):1352-1359. PubMed ID: 26013025
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of
Lee JR; Almuhaimid TM; Roh JL; Oh JS; Kim SJ; Kim JS; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2018 Sep; 118(4):644-650. PubMed ID: 30132891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
